Log in or Sign up for Free to view tailored content for your specialty!
Arrhythmia Disorders News
Two post-approval outcome trials of anti-hyperkalemia drug stopped for logistical reasons
AstraZeneca announced that two post-approval randomized heart- and kidney-related outcome studies of its anti-hyperkalemia drug have been stopped due to slow enrollment and low event rates.
Etripamil reduces ventricular rate in patients with AF
PHILADELPHIA — Etripamil, a nasal spray, reduced ventricular rate in patients with atrial fibrillation and rapid ventricular rate, researchers reported at the American Heart Association Scientific Sessions.
Log in or Sign up for Free to view tailored content for your specialty!
New atrial fibrillation guideline highlights early rhythm control, prevention strategies
An updated guideline on the prevention and management of atrial fibrillation includes a new staging system to emphasize disease progression, along with updated recommendations for catheter ablation and left atrial appendage occlusion.
News you may have missed from AHA 2023: SELECT, artificial intelligence, gene editing, more
Healio | Cardiology Today compiled a list of the top news from the 2023 American Heart Association Scientific Sessions.
Adhesive-based wearable cardioverter defibrillator beats performance goals
PHILADELPHIA — A novel adhesive-based wearable cardioverter defibrillator was associated with high rates of patient compliance and low rates of adverse events, researchers reported at the American Heart Association Scientific Sessions.
LAA exclusion system for use in AF during cardiac surgery cleared, launched in US
Medtronic announced the U.S. launch of its left atrial appendage exclusion system for use during cardiac surgery in patients with preoperative atrial fibrillation.
Physical activity and atrial fibrillation: Where’s the balance?
Atrial fibrillation is a common arrhythmia that increases risk for stroke, HF and dementia. Although AF risk increases with age, it can also occur in young people with normal hearts, sometimes called “lone AF.”
In AF hospitalization, more than 10% of DOAC doses off-label after discharge
PHILADELPHIA — Among patients hospitalized with atrial fibrillation discharged on a direct oral anticoagulant, more than 10% received an off-label dose, researchers reported at the American Heart Association Scientific Sessions.
Regular marijuana use linked to risk for HF, major adverse heart, brain events
PHILADELPHIA — Two observational studies presented at the American Heart Association Scientific Sessions linked regular marijuana use to elevated risk for HF and elevated risk for major adverse cardiac and cerebrovascular events.
Prototype pacemaker turns heartbeat energy into battery power
PHILADELPHIA — Researchers at the University of Washington have developed prototype piezoelectric devices to convert energy from a heartbeat into electricity that could recharge the battery of a leadless pacemaker.